Crowne Plaza Sun Palace , Beijing, China
May 15, 2011 - May 18 2011
As China unveils its 12th Five-Year Plan, the pharmaceutical industry remains
at a critical stage of innovation and reform. Facing new policies and
industry reorganization, a future elevation and sustainable development of
the industry requires revisiting Quality and Standards.
DIA invites you to attend the 3rd DIA China Annual Meeting. Let us jointly
explore the latest developments of the China pharmaceutical industry, and
exchange ideas that impact globally. Featuring open debate by senior professionals, top academics and highlevel
officials from Pharma, R&D and the regulatory field. KEY SESSIONS AND TOPICS
• CMC/cGMP
• Clinical Research, Drug Safety & Pharmacovigilance
• Regulation, Development & Practices
• Clinical Data Management and Statistics
• Medical and Scientifi c Aff airs
• Capability & Capacity Building, Clinical Development/Regulatory Strategy
• QA/QC in Clinical Development, Regulatory Requirements/Practices
Event Code:
11975
|
|